- Home
- OPK vs INVA Comparison
OPK vs INVA Comparison
Compare OPK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- INVA
- Stock Information
- Founded
- OPK 2007
- INVA 1996
- Country
- OPK United States
- INVA United States
- Employees
- OPK N/A
- INVA N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- INVA Health Care
- Exchange
- OPK Nasdaq
- INVA Nasdaq
- Market Cap
- OPK 1.0B
- INVA 1.3B
- IPO Year
- OPK 1995
- INVA 2004
- Fundamental
- Price
- OPK $1.38
- INVA $19.55
- Analyst Decision
- OPK Buy
- INVA Strong Buy
- Analyst Count
- OPK 4
- INVA 4
- Target Price
- OPK $2.75
- INVA $40.25
- AVG Volume (30 Days)
- OPK 1.9M
- INVA 648.8K
- Earning Date
- OPK 11-06-2025
- INVA 11-05-2025
- Dividend Yield
- OPK N/A
- INVA N/A
- EPS Growth
- OPK N/A
- INVA N/A
- EPS
- OPK N/A
- INVA 0.53
- Revenue
- OPK $664,029,000.00
- INVA $370,229,000.00
- Revenue This Year
- OPK N/A
- INVA $8.17
- Revenue Next Year
- OPK $0.84
- INVA $12.06
- P/E Ratio
- OPK N/A
- INVA $36.56
- Revenue Growth
- OPK N/A
- INVA 12.02
- 52 Week Low
- OPK $1.11
- INVA $16.67
- 52 Week High
- OPK $2.04
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- OPK 50.29
- INVA 43.69
- Support Level
- OPK $1.34
- INVA $19.11
- Resistance Level
- OPK $1.44
- INVA $21.11
- Average True Range (ATR)
- OPK 0.04
- INVA 0.47
- MACD
- OPK -0.00
- INVA -0.15
- Stochastic Oscillator
- OPK 40.00
- INVA 21.89
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.